DIAGNOSTIC INDUSTRY SHIFT TO INCREMENTAL PRODUCT IMPROVEMENTS
This article was originally published in The Gray Sheet
Executive Summary
DIAGNOSTIC INDUSTRY SHIFT TO INCREMENTAL PRODUCT IMPROVEMENTS rather than breakthrough advances is foreseen by Miles Diagnostics Executive VP for Worldwide Marketing, Sales and Service Rolf Classon. Addressing a meeting of the American Association for Clinical Chemistry on March 15, Classon said uncertainty due to health care reform and the movement toward managed care in health care delivery has facilitated a "change...not on the amount [diagnostics manufacturers] spend on research and development, but how we apply it."